vimarsana.com

Innovative Breast Cancer Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology

SAN JOSE - Anixa Biosciences, Inc. , a clinical-stage biotechnology company focused on the treatment and prevention of cancer, today announced that its collaborator, Cleveland Clinic, has received a.

Amit kumarMike catelaniSuparna mazumderVincent tuohyJustin johnsonAnixa biosciencesInnovative breast cancer researchAnixa biosciences incLerner research instituteJapan patent officeMoffitt cancer centerDepartment of inflammationNational cancer instituteOvarian cancer vaccinesIris november distinguished chairBreast cancer research

Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology

/PRNewswire/ Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a clinical-stage biotechnology company focused on the treatment and.

Amit kumarSuparna mazumderAnixa biosciencesVincent tuohyJustin johnsonMike catelaniAnixa biosciences incNational cancer instituteDepartment of inflammationMoffitt cancer centerCleveland clinic lerner research instituteJapan patent officeInnovative breast cancer researchCleveland clinicCancer vaccinesOvarian cancer vaccines

Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine

/PRNewswire/ Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer,.

United statesSan antonioMike catelaniAnixa biosciencesStephen kilmerAmit kumarG thomas buddVincent tuohyCleveland clinic lerner research instituteUs department of defenseInnovative breast cancer researchCleveland clinic cancer instituteDepartment of inflammationMoffitt cancer centerAnixa biosciences incCleveland clinic

Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine

/PRNewswire/ Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a clinical-stage biotechnology company focused on the treatment and.

United statesStephen kilmerAnixa biosciencesAxel ullrichMike catelaniJennifer davisBrian leyland jonesH michael shepardDennis slamonRobert weinbergVincent tuohyHarvard medical schoolInnovative breast cancer researchAnixa biosciences incDepartment of inflammationWarren alpert foundation prize

Anixa Biosciences Announces Opening of Enrollment for Keytruda® Arm in Ongoing Breast Cancer Vaccine Clinical Trial

/PRNewswire/ Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer,.

United statesMike catelaniAmit kumarAnixa biosciencesStephen kilmerCleveland clinic lerner research instituteAnixa biosciences incUs department of defenseMoffitt cancer centerInnovative breast cancer researchDepartment of inflammationCleveland clinicProgrammed cell deathSan antonio breast cancer symposiumMaximum tolerated doseIris november distinguished chair

vimarsana © 2020. All Rights Reserved.